✦ LIBER ✦

Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients

✍ Scribed by F.L. Luan; M. Samaniego; M. Kommareddi; J.M. Park; A.O. Ojo

Book ID: 110904429
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 155 KB
Volume: 12
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2010.00532.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus disease among donor-posi

Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis

✍ Dimitra Mitsani; M. Hong Nguyen; Eun J. Kwak; Fernanda P. Silveira; Aniket Vadne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 347 KB

The Efficacy and Safety of 200 Days Valg

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients

✍ A. Humar; Y. Lebranchu; F. Vincenti; E. A. Blumberg; J. D. Punch; A. P. Limaye; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Cytomegalovirus infection in kidney tran

Cytomegalovirus infection in kidney transplant recipients: early diagnosis and monitoring of antiviral therapy by the antigenemia assay

✍ T Said; M.R.N Nampoory; A.S Pacsa; K.V Johny; M.P Nair; M Abdel-Haleem; M Samhan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Beneficial Effects on the Renal Function

Beneficial Effects on the Renal Function of Both Recipients and Donors in Living Donor Kidney Transplantation

✍ C.K. Oh; S.N. Yoon; B.M. Lee; J.H. Kim; S.J. Kim; H. Kim; G.T. Shin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Immunoglobulin preparations from hepatit

Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients

✍ Prohaska, W. ;Wolff, C. ;Schl�ter, K. ;K�ster-Eiserfunke, W. ;K�rner, M.M. ;Klee 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 552 KB

All heart transplant patients in our clinic received intravenous immunoglobulins as a prophylaxis against cytomegalovirus infections or reactivations. Serum was sampled from 160 heart transplant patients within 4 months after surgery. In 98 samples (61%) hepatitis C virus (HCV)-specific antibodies c

The risk of cytomegalovirus infection in

The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: transfusion of blood products

✍ C.D. Hillyer; D.R. Snydman; E.M. Berkman 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 762 KB